Distinguishable Prognostic Signatures of Left- and Right-Sided Colon Cancer: a Study Based on Sequencing Data
Authors:
Open Access
- 17 July 2018
- journal article
- research article
- Published by S. Karger AG in Cellular Physiology and Biochemistry
- Vol. 48 (2) , 475-490
Abstract
Background/Aims: Left- and right-sided colon cancers are considered to be two different diseases and have altered outcomes. However, specific molecules to predict the prognosis of left- and right-sided colon cancers are currently lacking. Methods: Expression profiling of colon cancer were downloaded from The Cancer Genome Atlas (TCGA). Differentially expressed genes (DEGs) of left- and right-sided colon cancers were compared by DESeq analysis. The prognostic values of DEGs were assessed by univariate and multivariate Cox regression. Prognostic index models of two side colon cancers were conducted with prognostic values genes, respectively. Interaction of DEGs was then analyzed by the protein-protein interaction (PPI). Different biology function of two sides of colon cancer was assessed by Gene Set Enrichment Analysis (GSEA). Results: A total of 167 DEGs were identified between left- and right-sided colon cancers based on TCGA data. Using univariate COX regression analysis, five genes (PHACTR3, CKMT2, CYP2W1, ERFE, HOXC4) were related to overall survival in left-sided, and eight distinguishable genes (EREG, ERFE, HOXC6, SLC22A31, TFF1, GFI1, ZG16, RASL10B) in right-sided. Further, left-sided prognostic model was established with PHACTR3 and CKMT2 (HR=2.040; 95%CI=1.004-4.145; P=0.049). Distinguishable prognostic signature for right-sided colon cancer was established based on EREG, ERFE, GFI1, and RASL10B (HR=3.530; 95%CI: 1.934-6.444; P< 0.001) in multivariate analysis. PPI analysis of 167 DEGs showed that CCL5, GNG4, GNLY, GZMH, DRD2, and FASLG genes were at the core of interaction network. In GSEA function analysis, four pathways, including antigen processing and presentation, natural killer cell mediated cytotoxicity, intestinal immune network for Iga production, and type I diabetes mellitus, were significantly enriched in the DEGs of the right-sided colon cancer. Conclusions: This study constructs a panel of potential prognostic model of left- and right-sided colon cancers, respectively. We also provide molecular biological alterations between left- and right-sided colon cancers.Keywords
This publication has 50 references indexed in Scilit:
- Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancerBritish Journal of Cancer, 2016
- The Worse Prognosis of Right-Sided Compared with Left-Sided Colon Cancers: a Systematic Review and Meta-analysisJournal of Gastrointestinal Surgery, 2016
- Gene expression in colon cancer: A focus on tumor site and molecular phenotypeGenes, Chromosomes and Cancer, 2015
- The role of CD95 and CD95 ligand in cancerCell Death & Differentiation, 2015
- Chemokine (C-C Motif) Ligand 5 is Involved in Tumor-Associated Dendritic Cell-Mediated Colon Cancer Progression Through Non-Coding RNA MALAT-1Journal of Cellular Physiology, 2014
- B-RAF mutation and accumulated gene methylation in aberrant crypt foci (ACF), sessile serrated adenoma/polyp (SSA/P) and cancer in SSA/PBritish Journal of Cancer, 2014
- Proteomic and Functional Investigation of the Colon Cancer Relapse-Associated Genes NOX4 and ITGA3Journal of Proteome Research, 2014
- Right‐side and left‐side colon cancer follow different pathways to relapseMolecular Carcinogenesis, 2011
- The MTHFR C677T and ΔDNMT3B C‐149T polymorphisms confer different risks for right‐ and left‐sided colorectal cancerInternational Journal of Cancer, 2009
- Cloning and characterization of a novel small monomeric GTPase, RasL10B, with tumor suppressor potentialBiotechnology Letters, 2006